Aug 16, 2021 6:30am EDT BiomX Reports Second Quarter 2021 Financial Results and Provides Business Update
Aug 12, 2021 8:00am EDT BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021
Jun 14, 2021 6:30am EDT BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages
Jun 09, 2021 6:30am EDT BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference
May 24, 2021 6:30am EDT BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates
May 18, 2021 8:00am EDT BiomX To Host Key Opinion Leader Event on BX003 for the Treatment of Inflammatory Bowel Disease
May 18, 2021 6:30am EDT BiomX to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 24, 2021
